相关实验视频

Updated: May 25, 2025

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

通过在体内引导的方法发现了一种新的多标止痛药

Guo Zhen¹, Nayeon Do¹, Nguyen Van Manh¹

¹College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.

Pharmaceuticals (Basel, Switzerland)

|February 26, 2025

概括

一种新型的多目标止痛药,化合物29,通过抑制多巴胺和血清素载体和阻断5-HT2A受体,显示出强大的缓解疼痛. 进一步优化旨在提高其临床安全性.

科学领域:

药理学药理学是指药理学的学科.
神经科学是一个神经科学.
药物发现药物发现药物发现

背景情况:

疼痛是一种复杂的疾病,具有多种不同的促成因素,需要多目标治疗策略.
与单一向药物相比,多向止痛药通过减少副作用和耐受性来提高疗效和安全性.
识别具有改善药理学特征的新型止痛化合物对于有效的疼痛管理至关重要.

研究的目的:

发现和描述一种具有卓越药理性质的新型多目标止痛化合物.
评估新发现的化合物29的疗效和作用机制.
评估化合物29的药理动力学和安全性概况,以评估其潜在的临床应用.

主要方法:

一种在体内引导的查方法从一个新的支架中识别了化合物29.
在甲和脊髓神经绑定 (SNL) 疼痛模型中测试了有效性.
机理学研究研究了神经递质传递器和受体相互作用;进行了药理动力学和安全性评估.

主要成果:

化合物29在甲试验中表现出高强度 (ED50 0.78 mg/kg) 和在SNL模型中具有剂量依赖的止痛作用.
机制研究显示,多巴胺 (DAT) 和血清素 (SERT) 载体的强烈抑制和5-HT2A受体对抗作用.
化合物29显示出有利的药理动力学,包括稳定性和血脑屏障的透,但显示出潜在的hERG和CYP3A4抑制.

结论:

化合物29是一种有前途的多目标止痛药,具有显著的疗效和有利的药理动力学特性.
该化合物的机制涉及三重吸收抑制和5-HT2A受体对抗.
需要进一步优化,以减轻临床开发中发现的安全问题 (hERG,CYP3A4抑制).

关键词:

在体内以生物为导向的方法.多标止痛药是一种多标止痛药.这是一种新的止痛药.

更多相关视频

Intracranial Pharmacotherapy and Pain Assays in Rodents

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

Human In-Vivo Bioassay for the Tissue-Specific Measurement of Nociceptive and Inflammatory Mediators

Human In-Vivo Bioassay for the Tissue-Specific Measurement of Nociceptive and Inflammatory Mediators

Published on: December 1, 2008

相关概念视频

Analgesia and Pain Management

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...